Schroder Investment Management Group Fibrogen Inc Transaction History

Schroder Investment Management Group

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $4.61 Million - $38.1 Million	1,851,629 Added 123.04%	3,356,570 $9.06 Million
Q1 2023 May 11, 2023	SELL	$15.95 - $25.18 $4.08 Million - $6.44 Million	-255,809 Reduced 14.53%	1,504,941 $28.1 Million
Q4 2022 Feb 10, 2023	BUY	$13.27 - $17.73 $5.07 Million - $6.77 Million	381,778 Added 27.69%	1,760,750 $28.2 Million
Q3 2022 Nov 10, 2022	SELL	$11.4 - $14.6 $2.13 Million - $2.72 Million	-186,510 Reduced 11.91%	1,378,972 $17.9 Million
Q2 2022 Aug 11, 2022	SELL	$7.94 - $12.96 $331,360 - $540,859	-41,733 Reduced 2.6%	1,565,482 $17.1 Million
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $3.52 Million - $4.92 Million	293,256 Added 22.32%	1,607,215 $19.5 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $976,764 - $1.51 Million	-98,365 Reduced 6.96%	1,313,959 $18.5 Million
Q3 2021 Nov 12, 2021	BUY	$10.18 - $26.64 $3.58 Million - $9.38 Million	352,029 Added 33.2%	1,412,324 $14.4 Million
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $7.47 Million - $14.4 Million	402,463 Added 61.18%	1,060,295 $28.2 Million
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $20.4 Million - $36.7 Million	657,832 New	657,832 $22.8 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.